- Generic name
- Etoricoxib
- Strength
- 60 mg
- Dosage form
- Tablet
- Manufactured by
- Bengal Drugs & Chemical Works Pharm. Ltd.
Etocoxet-60 Tablet
About Etocoxet-60 Tablet
Etocoxet-60 60 mg tablet is a medicine made by Bengal Drugs & Chemical Works Pharm. Ltd. It does not treat the underlying disease; it relieves symptoms.
There are 90 brands of Etoricoxib listed in Bangladesh. The lowest listed price is Retoz 90 mg Tablet at ৳ 1 per unit.
What is Etocoxet-60 Tablet?
Etocoxet-60 60 mg is a tablet product of Bengal Drugs & Chemical Works Pharm. Ltd. that contains Etoricoxib. Etocoxet-60 is a tablet medicine with the active ingredient Etoricoxib, 60 mg per tablet. Doctors prescribe Etocoxet-60 for specific conditions such as acute gouty arthritis and other inflammatory joint problems. The dose and duration are set by the doctor based on your condition.
Uses of Etocoxet-60
It does not treat the underlying disease; it relieves symptoms. It is also used for short-term treatment of moderate pain after dental surgery. The doctor decides if it is suitable for you.
How to use Etocoxet-60
It can be taken with or without food. Etocoxet-60 is taken by mouth. Swallow the tablet with water. Take Etocoxet-60 exactly as your doctor or pharmacist tells you. The doctor decides the dose and the course of treatment for each person, so follow their instructions. The dose and duration depend on your condition and response to treatment; never change the dose or stop the medicine without consulting your doctor.
Side effects of Etocoxet-60
Like other NSAIDs, Etocoxet-60 60 mg tablet can cause side effects in some people. Less common effects include dry mouth, taste changes, mouth ulcers, appetite or weight changes, chest pain, flushing, cough, shortness of breath, nosebleeds, anxiety, reduced mental sharpness, tingling, electrolyte disturbance, and muscle or joint pain. Tell your doctor if you notice any side effects. Tell your doctor if any side effect worries you or does not go away.
Safety and precautions
Etocoxet-60 60 mg tablet is not recommended during pregnancy or breastfeeding, and women who take Etoricoxib must not breastfeed. The elderly and those with heart risk factors need careful evaluation. Do not take it if you are allergic to Etoricoxib or any of its ingredients, or if you have had allergic-type reactions to aspirin or other NSAIDs. Tell your doctor about all your conditions and medicines, and ask before starting it.
Frequently asked questions
What is Etocoxet-60 used for?
It does not treat the underlying disease; it relieves symptoms. It is also used for short-term treatment of moderate pain after dental surgery.
How should I take Etocoxet-60?
It can be taken with or without food. Etocoxet-60 is taken by mouth.
Can Etocoxet-60 cause side effects?
Like other NSAIDs, Etocoxet-60 60 mg tablet can cause side effects in some people. Less common effects include dry mouth, taste changes, mouth ulcers, appetite or weight changes, chest pain, flushing, cough, shortness of breath, nosebleeds, anxiety, reduced mental sharpness, tingling, electrolyte disturbance, and muscle or joint pain.
Is Etocoxet-60 safe for everyone?
Etocoxet-60 60 mg tablet is not recommended during pregnancy or breastfeeding, and women who take Etoricoxib must not breastfeed. The elderly and those with heart risk factors need careful evaluation.
Indications
- Osteoarthritis (OA)
- Rheumatoid arthritis (RA)
- Ankylosing spondylitis, and
- The pain and signs of inflammation associated with acute gouty arthritis.
- For the short-term treatment of moderate pain associated with dental surgery.
Pharmacology
Dosage & Administration
- Osteoarthritis: The recommended dose is 30 mg once daily. In some patients with insufficient relief from symptoms, an increased dose of 60 mg once daily may increase efficacy.
- Rheumatoid arthritis: The recommended dose is 90 mg once daily.
- Ankylosing spondylitis: The recommended dose is 90 mg once daily.
- Acute gouty arthritis: The recommended dose is 120 mg once daily. In clinical trials for acute gouty arthritis, Etoricoxib was given for 8 days.
- Postoperative dental surgery pain: The recommended dose is 90 mg once daily, limited to a maximum of 3 days.
Interaction
- Oral anticoagulants: In subjects stabilized on chronic warfarin therapy, the administration of Etoricoxib was associated with an increase in prothrombin time.
- Diuretics, ACE inhibitors and Angiotensin II Antagonists: NSAIDs may reduce the effect of diuretics and other antihypertensive drugs.
- Acetylsalicylic Acid: Etoricoxib can be used concomitantly with acetylsalicylic acid at doses used for cardiovascular prophylaxis (low-dose acetylsalicylic acid).
- Ciclosporin and tacrolimus: Although this interaction has not been studied with Etoricoxib, coadministration of ciclosporin or tacrolimus with any NSAID may increase the nephrotoxic effect of ciclosporin or tacrolimus.
- Lithium: NSAIDs decrease lithium renal excretion and therefore increase lithium plasma levels.
Contraindications
- Hypersensitivity to the active substance or to any of the excipients.
- Active peptic ulceration or active gastro-intestinai (Gl) bleeding.
- Patients who have experienced bronchospasm, acute rhinitis, nasal polyps, angioneurotic oedema, urticaria, or allergic-type reactions after taking acetylsalicylic acid or NSAIDs including COX-2 (cyclooxygenase-2) inhibitors.
- Pregnancy and lactation.
- Severe hepatic dysfunction (serum albumin <25 g/l or Child-Pugh score 10).
- Estimated renal creatinine clearance <30 ml/min.
- Children and adolescents under 16 years of age.
- Inflammatory bowel disease.
- Congestive heart failure (NYHA ll-IV).
- Patients with hypertension whose blood pressure is persistently elevated above 140/90 mmHg and has not been adequately controlled.
- Established ischaemic heart disease, peripheral arterial disease, and/or cerebrovascular disease.
Side Effects
Pregnancy & Lactation
Precautions & Warnings
- Caution is advised with treatment of patients most at risk of developing a gastrointestinal complication with NSAIDs; the elderly, patients using any other NSAID or acetylsalicylic acid concomitantly or patients with a prior history of gastrointestinal disease, such as ulceration and Gl bleeding.
- Patients with significant risk factors for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking) should only be treated with Etoricoxib after careful consideration.
- Administration of Etoricoxib may cause a reduction in prostaglandin formation and, secondarily, in renal blood flow, and thereby impair renal function. Monitoring of renal function in such patients should be considered.
- Caution should be exercised in patients with a history of cardiac failure, left ventricular dysfunction, or hypertension and in patients with pre-existing edema from any other reason.
- Any patients with symptoms and/or signs suggesting liver dysfunction, or in whom an abnormalliver function test has occurred, should be monitored. If signs of hepatic insufficiency occur, or if persistently abnormal liver function tests (three times the upper limit of normal) are detected, Etoricoxib should be discontinued.
- Etoricoxib should be discontinued at the first appearance of skin rash, mucosal lesions, or any other sign of hypersensitivity.
- Etoricoxib may mask fever and other signs of inflammation. Caution should be exercised when co-administering Etoricoxib with warfarin or other oral anticoagulants.
Overdose Effects
Storage Conditions
Alternative brands of Etoricoxib
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.